Sign In

Login

Password

Forgot Password ? Sign Up

Carboxymaltose ferrique (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "Carboxymaltose ferrique" in French language version.

refsWebsite
Global rank French rank
9nih.gov
4th place
12th place
8doi.org
2nd place
3rd place
1qmul.ac.uk
1,735th place
168th place

doi.org

dx.doi.org

  • P. Geisser, J. Banké-Bochita, Pharmacokinetics, safety and tolerability of intravenous ferric carboxymaltose: a dose-escalation study in volunteers with mild iron-deficiency anaemia, In: Arzneimittelforschung, vol. 60, no 6a, 2010, p. 362–372 DOI 10.1055/s-0031-1296301, PMID 20648928.
  • S. Kulnigg, S. Stoinov, V. Simanenkov, L. V. Dudar, W. Karnafel, L. C. Garcia, A. M. Sambuelli, G. D'Haens, C. Gasche, A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial, In: Am. J. Gastroenterol, vol. 103, no 5, mai 2008, p. 1182–1192 DOI 10.1111/j.1572-0241.2007.01744.x, PMID 18371137.
  • P. Ponikowski, D. J. van Veldhuisen, J. Comin-Colet, G. Ertl, M. Komajda, V. Mareev, T. McDonagh, A. Parkhomenko, L. Tavazzi, V. Levesque, C. Mori, B. Roubert, G. Filippatos, F. Ruschitzka, S. D. Anker, Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency†, In: Eur. Heart J., vol. 36, no 11, mars 2015, p. 657–668, DOI 10.1093/eurheartj/ehu385, PMID 25176939, PMC 4359359.
  • I. C. Macdougall, A. H. Bock, F. Carrera, K. U. Eckardt, C. Gaillard, D. Van Wyck, B. Roubert, J. G. Nolen, S. D. Roger, FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia, In: Nephrol. Dial. Transplant, vol. 29, no 11, novembre 2014, p. 2075–2084, DOI 10.1093/ndt/gfu201, PMID 24891437, PMC 4209879.
  • M. H. Seid, R. J. Derman, J. B. Baker, W. Banach, C. Goldberg, R. Rogers, Ferric carboxymaltose injection in the treatment of postpartum iron deficiency anemia: a randomized controlled clinical trial, In: Am. J. Obstet. Gynecol, vol. 199, no 4, octobre 2008, p. 435e1–435.e7, DOI 10.1016/j.ajog.2008.07.046, PMID 18928998.
  • B. Favrat, K. Balck, C. Breymann, M. Hedenus, T. Keller, A. Mezzacasa, C. Gasche, Evaluation of a single dose of ferric carboxymaltose in fatigued, iron-deficient women–PREFER a randomized, placebo-controlled study, In: PLoS ONE, vol. 9, no 4, 2014, p. 94217, DOI 10.1371/journal.pone.0094217, PMID 24751822, PMC 3994001.
  • C. Breymann, N. Milman, A. Mezzacasa, R. Bernard, J. Dudenhausen, Ferric carboxymaltose vs. oral iron in the treatment of pregnant women with iron deficiency anemia: an international, open-label, randomized controlled trial (FER-ASAP), In: J Perinat Med, juin 2016, DOI 10.1515/jpm-2016-0050, PMID 27278921.
  • R. Evstatiev, P. Marteau, T. Iqbal, I. L. Khalif, J. Stein, B. Bokemeyer, I. V. Chopey, F. S. Gutzwiller, L. Riopel, C. Gasche, FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease, In: Gastroenterology, vol. 141, no 3, septembre 2011, p. 846–853 e1, DOI 10.1053/j.gastro.2011.06.005, PMID 21699794.

nih.gov

ncbi.nlm.nih.gov

  • S. Beshara, J. Sörensen, M. Lubberink, V. Tolmachev, B. Långström, G. Antoni, B. G. Danielson, H. Lundqvist, Pharmacokinetics and red cell utilization of 52Fe/59Fe-labelled iron polymaltose in anaemic patients using positron emission tomography, In: Br. J. Haematol., vol. 120, no 5, mars 2003, p. 853–859 PMID 12614222.
  • P. Geisser, J. Banké-Bochita, Pharmacokinetics, safety and tolerability of intravenous ferric carboxymaltose: a dose-escalation study in volunteers with mild iron-deficiency anaemia, In: Arzneimittelforschung, vol. 60, no 6a, 2010, p. 362–372 DOI 10.1055/s-0031-1296301, PMID 20648928.
  • S. Kulnigg, S. Stoinov, V. Simanenkov, L. V. Dudar, W. Karnafel, L. C. Garcia, A. M. Sambuelli, G. D'Haens, C. Gasche, A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial, In: Am. J. Gastroenterol, vol. 103, no 5, mai 2008, p. 1182–1192 DOI 10.1111/j.1572-0241.2007.01744.x, PMID 18371137.
  • P. Ponikowski, D. J. van Veldhuisen, J. Comin-Colet, G. Ertl, M. Komajda, V. Mareev, T. McDonagh, A. Parkhomenko, L. Tavazzi, V. Levesque, C. Mori, B. Roubert, G. Filippatos, F. Ruschitzka, S. D. Anker, Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency†, In: Eur. Heart J., vol. 36, no 11, mars 2015, p. 657–668, DOI 10.1093/eurheartj/ehu385, PMID 25176939, PMC 4359359.
  • I. C. Macdougall, A. H. Bock, F. Carrera, K. U. Eckardt, C. Gaillard, D. Van Wyck, B. Roubert, J. G. Nolen, S. D. Roger, FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia, In: Nephrol. Dial. Transplant, vol. 29, no 11, novembre 2014, p. 2075–2084, DOI 10.1093/ndt/gfu201, PMID 24891437, PMC 4209879.
  • M. H. Seid, R. J. Derman, J. B. Baker, W. Banach, C. Goldberg, R. Rogers, Ferric carboxymaltose injection in the treatment of postpartum iron deficiency anemia: a randomized controlled clinical trial, In: Am. J. Obstet. Gynecol, vol. 199, no 4, octobre 2008, p. 435e1–435.e7, DOI 10.1016/j.ajog.2008.07.046, PMID 18928998.
  • B. Favrat, K. Balck, C. Breymann, M. Hedenus, T. Keller, A. Mezzacasa, C. Gasche, Evaluation of a single dose of ferric carboxymaltose in fatigued, iron-deficient women–PREFER a randomized, placebo-controlled study, In: PLoS ONE, vol. 9, no 4, 2014, p. 94217, DOI 10.1371/journal.pone.0094217, PMID 24751822, PMC 3994001.
  • C. Breymann, N. Milman, A. Mezzacasa, R. Bernard, J. Dudenhausen, Ferric carboxymaltose vs. oral iron in the treatment of pregnant women with iron deficiency anemia: an international, open-label, randomized controlled trial (FER-ASAP), In: J Perinat Med, juin 2016, DOI 10.1515/jpm-2016-0050, PMID 27278921.
  • R. Evstatiev, P. Marteau, T. Iqbal, I. L. Khalif, J. Stein, B. Bokemeyer, I. V. Chopey, F. S. Gutzwiller, L. Riopel, C. Gasche, FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease, In: Gastroenterology, vol. 141, no 3, septembre 2011, p. 846–853 e1, DOI 10.1053/j.gastro.2011.06.005, PMID 21699794.

qmul.ac.uk

chem.qmul.ac.uk